Journal
BMC WOMENS HEALTH
Volume 22, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12905-022-02040-1
Keywords
Colorectal cancer (CRC); Prophylactic salpingo-oophorectomy (PSO); Survival; Number needed to treat; Study protocol
Ask authors/readers for more resources
The study aims to evaluate the effect of prophylactic salpingo-oophorectomy (PSO) in postmenopausal patients with colorectal cancer (CRC). Information bulletins and decision guides will be implemented in several Dutch hospitals to collect prospective data and estimate the incidence of ovarian metastases (OM) and primary ovarian cancer. The expected results will provide valuable information on the necessity of PSO in postmenopausal CRC patients.
Background: The mean incidence of ovarian metastases (OM) in patients with colorectal cancer (CRC) is 3.4%. The 5-year survival of these patients, even when operated with curative intent, is remarkably low. The lifetime risk of ovarian cancer is approximately 1.3%. Prophylactic salpingo-oophorectomy (PSO, or surgical removal of the ovaries and fallopian tubes) could reduce the number of CRC patients that develop OM after removal of the primary tumor, as well as preventing the occurrence of primary ovarian cancer. Recently, the care pathway for CRC has been changed in several hospitals in line with the updated Dutch guideline. The possibility of PSO is now discussed with postmenopausal CRC patients in these hospitals. The aims of the current study are firstly to estimate the incidence of OM and primary ovarian cancer in postmenopausal patients with CRC, and secondly to evaluate the effect of PSO in these patients. Methods: An information bulletin and decision guide on this topic was implemented in several Dutch hospitals in 2020. Post-decision outcomes will be collected prospectively. The study population consists of postmenopausal (>= 60 years of age) patients that are operated with curative intent for CRC. Based on their own preference, patients will be divided into two groups: those who choose to undergo PSO and those who do not. The main study parameters are the reduction in incidence of ovarian malignancies (metastatic or primary) following PSO, and the number needed to treat (NNT) by PSO to prevent one case of ovarian malignancy. Discussion: This will be the first study to evaluate the effect of PSO in postmenopausal CRC patients that is facilitated by an altered CRC care pathway. The results of this study are expected to provide relevant information on whether PSO adds significant value to postmenopausal patients with CRC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available